[Federal Register Volume 76, Number 228 (Monday, November 28, 2011)]
[Pages 72954-72955]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-30415]



Food and Drug Administration

[Docket No. FDA-2011-N-0002]

Request for Nominations for Voting Members on Public Advisory 
Committee, Science Board to the Food and Drug Administration

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.


    The Food and Drug Administration (FDA) is requesting nominations 
for voting members to serve on the Science Board to the FDA (the 
Science Board).
    FDA has special interest in ensuring that women, minority groups, 
and individuals with disabilities are adequately represented on 
advisory committees and, therefore, encourages nominations of qualified 
candidates from these groups.

DATES: Nominations received on or before December 28, 2011, will be 
given first consideration for membership on the Science Board. 
Nominations received after December 28, 2011, will be considered for 
nomination to the Science Board should nominees still be needed.

ADDRESSES: All nominations for membership should be sent electronically 
to [email protected], or by mail to Advisory Committee Oversight & 
Management Staff, 10903 New Hampshire Ave., Bldg. 32, Rm. 5103, Silver 
Spring, MD 20993-0002.

FOR FURTHER INFORMATION CONTACT: Regarding all nomination questions for 
membership, the primary contact is: Martha Monser, Office of the Chief 
Scientist, Food and Drug Administration, 10903 New Hampshire Ave., 
Bldg. 32, Rm. 4286, Silver Spring, MD 20993-0002, (301) 796-4627, 
email: [email protected].

Information about becoming a member on an FDA advisory committee can 
also be obtained by visiting FDA's Web site by using the following 
link: http://www.fda.gov/oc/advisory/default.htm.

SUPPLEMENTARY INFORMATION: FDA is requesting nominations for voting 
members on the Science Board.

I. General Function of the Committee

    The Science Board shall provide advice primarily to the 
Commissioner of Food and Drugs (the Commissioner) and other appropriate 
officials on both general and specific scientific and technical issues 
as well as emerging issues within the scientific community. 
Additionally, the Science Board will

[[Page 72955]]

provide advice to the Agency on keeping pace with technical and 
scientific advances in the fields of regulatory science; on formulating 
an appropriate research agenda; and on upgrading its scientific and 
research facilities to keep pace with these changes. It will also 
provide the means for critical review of Agency strategic science plan 
and its implementation as well as of related intramural and extramural 
scientific research and training.

II. Criteria for Voting Members

    Members and the Chair are selected by the Commissioner or designee 
from among authorities knowledgeable in the fields of food safety, 
nutrition, chemistry, pharmacology, toxicology, clinical research, and 
other scientific disciplines. Members shall represent academia and 
industry. The Science Board may include one technically qualified 
member, selected by the Commissioner or designee, who is identified 
with consumer interests and is either recommended by either a 
consortium of consumer oriented organizations or other interested 
persons. The Science Board may also include technically qualified 
federal members. FDA is currently specifically seeking persons 
knowledgeable in the fields of pharmacology, translational and clinical 
medicine, toxicology, clinical research and related biostatistics, 
public health and epidemiology, international public health and 
regulation, product safety, product manufacturing sciences and quality 
or other scientific areas relevant to FDA regulated products such as 
systems biology, advanced scientific informatics, nanotechnology, food 
sciences, medical devices and combination products.

III. Nomination Procedures

    Any interested person may nominate one or more qualified persons 
for membership on the Science Board. Self nominations are also 
accepted. Nominations shall include the name of the committee, complete 
curriculum vitae of each nominee, and their current business address 
and telephone number and email address if available. Nominations must 
specify the advisory committee for which the nominee is recommended. 
Nominations must also acknowledge that the nominee is aware of the 
nomination, unless self nominated. FDA will ask potential candidates to 
provide detailed information concerning such matters as financial 
holdings, employment, and research grants and/or contracts.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14 relating to advisory committees.

    Dated: November 21, 2011.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2011-30415 Filed 11-25-11; 8:45 am]